Virax Biolabs VRAX
NASDAQ VRAX
$3.19 -0.26 (-7.39%)
As of: Aug 21, 2026 · 3:59 PM EDT

Virax Biolabs (VRAX) Inventory (2021 - 2025)

Virax Biolabs (VRAX) posted quarterly Inventory of $94675.0 for Q1 2025, up 56.79% year-over-year from $60383.0 in Q1 2024, and down 24.41% quarter-over-quarter from $125255.0 in Q3 2024.

Virax Biolabs (VRAX) Inventory (2021 - 2025) Analysis & Trends

Virax Biolabs' Inventory history runs 4 years deep, the most recent figure standing at $94675.0 for Q1 2025.

  • In Q1 2025, Inventory rose 56.79% year-over-year to $94675.0; the TTM figure through Mar 2025 stood at $94675.0 (up 56.79% YoY), while the FY2025 annual figure was $94675.0, up 56.79% from the prior year.
  • Inventory for Q1 2025 stood at $94675.0, down from $125255.0 in the prior quarter.
  • The five-year high for Inventory was $125255.0 in Q3 2024, with the low at $20951.0 in Q1 2022.
  • The 4-year median for Inventory is $60383.0 (2024), against an average of $64467.2.
  • The sharpest annual moves came in 2022 and 2025: Inventory slipped 0.57% in 2022, then jumped 56.79% in 2025.
  • Virax Biolabs' Inventory stood at $21072.0 in 2021, then declined by 0.57% to $20951.0 in 2022, then surged by 497.85% to $125255.0 in 2024, then retreated by 24.41% to $94675.0 in 2025.
  • Business Quant data shows VRAX's Inventory at $94675.0 in Q1 2025, $125255.0 in Q3 2024, and $60383.0 in Q1 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inventory (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.77 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 3.08 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 371.00 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 280.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 732.60 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 97.11 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 128.86 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 142.38 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Virax Biolabs 1.31 Mn -5.13 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2025 94,675.00
Sep 30, 2024 125,255.00
Mar 31, 2024 60,383.00
Mar 31, 2022 20,951.00
Mar 31, 2021 21,072.00